ASCO 2017 - Lung Cancer - A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line Treatment

H. Jack West, MD, Founder, President and CEO

Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer.   In this roundtable video, the doctors discuss A Practice Change for ALK+ Lung Cancer Patients, Alecensa for First Line Treatment.

 


 

 

GRACE would like to thank the following sponsors for their support of this program


 

snip_asco_sponsors

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation